AmTrust Financial Services
Standard Pacific

This year's Fastest-Growing Companies marks the 19th running of the list.

See our methodology and credits



To qualify, a company-domestic or foreign-must be trading on a major U.S. stock exchange; report data in U.S. dollars; file quarterly reports with the SEC; have a minimum market capitalization of $250 million and a stock price of at least $5 on June 30, 2015; and have been trading continuously since June 30, 2012. Companies must have revenue and net income for the four quarters ended on or before April 30, 2015, of at least $50 million and $10 million, respectively; and have posted an annualized growth in revenue and earnings per share of at least 15% annually over the three years ended on or before April 30, 2015.

Companies that meet these criteria are ranked by revenue growth rate; EPS growth rate; and three-year annualized total return for the period ended June 30, 2015. (To compute the revenue and EPS growth rates, Fortune uses a trailing four quarters log linear least square regression fit.)

The overall rank is based on the sum of the three ranks. Once the 100 companies are identified, they are then re-ranked within the 100, using the three equally weighted variables. If there is a tie, the company with the larger four-quarter revenue receives the higher rank.

Excluded are real estate investment trusts, limited liability companies, limited partnerships, business development companies, closed end investment firms, companies about to be acquired, and companies that lost money in the quarter ended on or before April 30, 2015. In addition, Fortune excludes companies that have announced intentions to restate previously reported financial data, if these errors appear to have a significant impact. Also, Fortune excludes companies that lost money in the quarter ended May 31 or June 30, if the loss represents a deterioration in business conditions. The data are provided by Zacks Investment Research. The data checking process was aided by information provided by S&P Capital IQ, Hoover’s, FactSet Research Systems, and Morningstar Document Research.

—By Scott DeCarlo, Douglas G. Elam, Orlaith Farrell, Vivian Giang, Kathleen Smyth

This year's Fastest-Growing Companies marks the 19th running of the list. In our annual list of public companies with the most stellar three-year profit, revenue, and stock growth, Facebook makes its first appearance.

See our methodology and credits


Sort by:
  1. Rank
  2. Revenues
  3. Profits
  4. Mkt Value
  5. Rev Growth
  6. Total Return
Clear Filters

Filter by

Fastest Growing Stats
Gained in Rank
Dropped in Rank
Clear Filters

Clear Filters

View The Full List


Suresh Chintalapati, an inside sales consultant with Illumina, displays a flow cell, the slide on which DNA is sequenced in the Miseq, a their bench top DNA sequencing machine, during a symposium on "The Future of Genomic Medicine" at Scripps Seaside Forum in La Jolla, California.
Photograph by Sam Hodgson — Reuters

High demand for genetic sequencing tests helped biotech manufacturer boost revenues 31% last year. (Employees are not in fact referred to as “illuminati.”)

Company Information

Location San Diego, CA
Industry Pharmaceuticals
Sector Health Care
Fortune 500 Rank -
Fortune 500 Profile -
Current Streak 1
Years on List 3
CEO Jay T. Flatley

Revenue, Net Income

$ millions
Revenue Past Four Quarters 1979
Net Income Past Four Quarters 430

Growth Rates

EPS 3 yr Annual Growth Rate 58%
Rev 3 yr Annual Growth Rate 23%
Total Return 3 yr Annual Rate 76%
Beat S&P 3 yr Total Return?


EPS Growth Rank 40
Revenue Growth Rank 75
Total Return Rank 13
Fortune's Take On Illumina
  • Commentary: Attacking Biology’s Complexity with New Genomics Approaches
    An Illumina co-founder and Venrock's Bryan Roberts weigh in.
  • The 5 Best Biotech and Health Care Stocks to Buy for 2019 Now That Congress Can’t Repeal Obamacare
    With Congress split between Republicans and Democrats, pharma and biotech stocks are ready to surge.
  • These Are the Health Care Companies Poised for Explosive Growth
    From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.
  • Microsoft Chairman John Thompson Talks Cloud Competition, Diversity, and New Rubrik Board Seat
    Thompson shares his thoughts.
  • Sign In


    Thank you for your interest in licensing Fortune content. Please find information on various licensing contacts below and choose the one that best suits your needs:

    • 1. To license Fortune articles, excerpts, or headlines for republication in various media (including books, eBooks, film, web, newsletters, newspapers, magazines and others), please email
    • 2. To license a Fortune cover, order reprint or e-print copies of an article or cover, or license an accolade, please contact PARS International at
    • 3. To license text only photocopies of Fortunearticles as print or digital handouts in academic settings, or in academic coursepacks, please contact the Copyright Clearance Center at